Good the very of on Thank to and quarter everybody profit for XXXX, Novanta in both well Ray. morning our joining and shareholders. performed first our call. delivering our you, revenue thanks promises
Our company delivered and revenue, reported X% on organic a representing $XXX.X basis. million revenue year-over-year in both growth
macro over per the confident was Our was EBITDA remain medical $X.XX, XX% half was $X.XX We our $XX.X adjusted are share which positioning our up about from last revenue that of with year. growth million. drivers growing. around secular in of earnings businesses Adjusted structurally markets
our productivity. vision excited We healthcare trend and photonics continue we customers. as for and see such and motion of growth Industry material in new to first and a innovations advanced and on X.X, penetrate the in sequencing, robotic high to momentum quarter, of efforts about a precision long-term large DNA medicine to to solid back in our position our of continued and markets need processing the variety trends success surgery, robotics. and precision macro see we capabilities remain surgery, In minimally introduce applications applications invasive Particularly, automation
the year-over-year. grew revenue XX% quarter product first New over for
remains is launched the quarter. first new revenue sales which in last XX% years Index, Vitality from of Our the products four above for well
and we segments. win continued increased see sustained System wins all, early design team growth operating by our all quarter quarter driving to the as the in in Novanta strong performance first we had XX%, design by of All implementing over our our benefits a first operating Growth Our of with performance. very growth in broad-based
in we're climate. what our in seeing the on macroeconomic markets touch overall me let Now,
the invasive full out expect temporary and year-over-year in pleased dynamics, I sequencing customer Our reported growth our DNA with XX% growth medical markets which in medical a minimally climate. that based, we first and continue XXXX. as in have double-digit momentum is particularly double-digit point serve business in of due quarter that in double-digit sold XXXX in of revenue, to growth we despite robotic year decline the for We our surgery. Representing our Momentum in we're macroeconomic to are medical are uncertain previously medical business our also engine markets expect but on. our would over momentum very launch broad robust. to we achieving to our like an
the side decline We growth to digits. be is spectrum is XX% spending expect uncertainty which microelectronics our reported but while of revenue the quarter momentum the first is capital rest creating our China and an this markets has mentality widely in to a persist opposite first We we industrial a the of quarter. modest the most of our Europe, XXXX. for year-over-year portfolio, see at mid-single part softening On headwind, And overall digits grew spreading as the Asia in across in noticeable of markets. for saw trade been the wait-and-see double XX% of down industrial of the it's remainder market, and the which to year uncertainty of slightly
far However, is so not uncertainty broad this based.
in the momentum we're momentum. on nice example, growing of For additive seeing market are back double-digit manufacturing, laser share we good growth where
I just China growth dynamics market explained. overall our mirroring Finally, is the
mid year-over-year Our medical China whereas our were into the digits sales businesses double down up by digits. were but microelectronics industrial low and declined single quarter, single in first digits sales our sales
As to relatively is sales. a of reminder, approximately at China revenue Novanta's XX% China's modest --
Now let me turn operating to our segments.
growth. revenue segment had Motion Our Precision year-over-year XX%
to with Ingenia a control start-up is customers technology our company of OEM technology Ingenia's acquisition generation position less companies nitride next in We such on addition gallium high completed and of heat motion precision customers an called performance, footprint This magnitude, In we lower first ultra as continue multiple servo is servo offer small weight. motion dynamics close one and and robotic power drives. surgery on business and Ingenia based markets. our tuck-in critical factors portfolio. or high a serving and provides weight for technologies control precision and small growth April, of customized order structural encoders robotics applications. fantastic precise form precision automation, markets We of technology, control technologies, reducing with is to metrology robotics, integration motion in solutions a with motion which GaN and dynamic like enables precision motors believe our particularly automation solutions size. GaN, Ingenia's with this allow the controls to Ingenia. based
to these forward high-growth is solutions us subsystem selling and application opportunities the While Ingenia is in small, to business capture a in developing areas. strong customers, intelligent positioning step well strategically the acquisition our
segment expanding first Motion design was as mentioned we market robotic Precision we softness earlier, book-to-bill the commercial the Precision in motion to quarter, momentum partly fantastic innovations offset first Within and that are by year versus microelectronics wins last for market the quarter to teams. our new the in X.XX our grew due XX% bring surgery.
Turning Revenue was to mainly segment. Quantum. performance X% Laser of the down our Photonics by driven
is indicated but the in second the the This growth in quarter quarter as to after the first do of we year. business expected. market revenue Laser XXXX, before in expect return expect the calls, of year-over-year half XXXX. second we in in digits in event business to new sequencing facing an of declined double DNA comparisons As Quantum we prior the repeat the is to prior a product Laser launch Quantum a challenging customer's year-over-year
in a which launch market As related dynamics to reminder, this growth. end in temporary sequencing, unrelated is sales lumpiness DNA to customer is
numerous sequencing as about applications the prospects In excited DNA with business fact, of of this stages clinical early growth we long-term on couldn't is penetration catalysts positive the feel in horizon. the more still into
sales just addition, at impacted in Synrad the this is medical particularly sequencing. The capital headwinds feel end discussed the segment we by on temporary some and excluding of of markets segment when now In macroeconomic serve strong in platforms performance industrial which multi-generational the our also Photonics in space. saw the markets securely sensitive The of digits Photonics was we spending DNA we're to. that position double business dynamics in growing we
sales. quarter well quarter, grew wins Photonics from mid above For XX% the new of grew total the Photonics in and was revenue product for China also revenue first pleased robust macroeconomic digit single-digit first Design business, first quarter, revenue which We're despite mid-single delivered despite the in to challenges. market our year-over-year the solid execution growth Cambridge growth still continued Technology challenging in year-over-year see year-over-year climate.
our beam technology with the to proprietary customer solutions packaged enabling and steering due solutions. winning application-specific to are customers with highest accurate performing or fastest, We win our most
with the quarter our segment, which carrying into the year. rest growth was strong this the to momentum Turning star Vision of
The Vision launch serves expect medical progress double bill well digits than For which market product X.XX new the with The segment to the growth. core sales. doubled year-over-year our new last momentum Vision solid market the products XX% predominantly product nearly product through and Vision for board. year launches driven was across quarter, in momentum, of as see was delivered the quarter. as solid year-over-year new we Design and new book mentioned, to the Vision XXXX. grew our greater excellent by the first XX% segment in quarter Growth we strong first previously revenue revenue as new at bookings product customers. was In segment and segment, total versus revenue continue we as wins
for a the well XXXX the Our from WOM momentum team. WOM performed first This high quarters. quarter as the demand testament extremely to commercial as product WOM's offerings well execution is of in the both its business continuing few last by
operating NDS very image are which wireless products of XK video the NDS our integrated momentum and such market. delivered the the first consecutive product by revenue pleased new room its our we driven product new continued ninth VIMA, growth with of acquisition quarter quarter, In products year-over-year and or core addition, addresses In line. management as displays,
business profitability quarter and was revenue of the first XXXX profit addition, growth. a meaningful In driver our improved substantially and its
Finally, show business momentum. Detection solid Analysis to continued our &
contributor on to first growth. markets RFID Despite that launches business of Vision XXXX a and in providing continued the Vision uncertain solid profitability product ourselves approach around quarter the we we're continue markets. to for climate, for strongly combined In New especially diversified organic first strong medical its of our beyond into product in positions profitable growth industrial medical macroeconomic was offerings. and offerings. with Overall, the sustained disciplined quarter our medical with net position teams and XXXX Machine foundation achieved revenue the in is product pleased leadership to revenue M&A more RFID growth how expanding and going Novanta's and with a sustainable growth XXXX focus the across and grade growth our with Machine
our call Robert? So with on that, will over I provide to turn to more Robert performance. financial the details